HOTH
Hoth Therapeutics Inc
NASDAQ: HOTH · HEALTHCARE · BIOTECHNOLOGY
$0.71
-2.70% today
Updated 2026-04-29
Market cap
$13.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$0 – $2
Volume
3.1M
Hoth Therapeutics Inc (HOTH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-465243.00 | $-2.10M | $-4.95M | $-6.13M | $-12.09M | $-9.30M | $-8.45M | $-6.98M | $-9.80M |
| Capital expenditures | $303680.00 | $0.00 | $95000.00 | $167457.00 | $116970.00 | $74000.00 | $4.00 | $0.00 | $0.00 |
| Depreciation | $188.00 | $1224.00 | $1225.00 | $1043.00 | $124.00 | — | — | — | — |
| Stock-based comp | $1.47M | $143053.00 | $2.50M | $737746.00 | $1.32M | $620798.00 | $216428.00 | $804277.00 | $1.19M |
| Free cash flow | $-768923.00 | $-2.10M | $-5.04M | $-6.30M | $-12.21M | $-9.37M | $-8.45M | $-6.98M | $-9.80M |
| Investing cash flow | $-303680.00 | $-895000.00 | $-895000.00 | $-1.84M | $-165355.00 | $1.16M | — | — | — |
| Financing cash flow | $2.00M | $1.15M | $7.45M | $8.73M | $18.19M | $6.04M | $11.32M | $4.74M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $-947819.00 | $1.61M | $738804.00 | — | — | — | — | — |